Heart disease in infancy: A window to the world of fetal cardiology

Iosif W. Lurie, Charlotte Ferencz, Joel Brenner

Research output: Contribution to journalArticle

Abstract

Advances in ultrasound technology and its widespread application have enabled the discovery of the most serious cardiovascular malformations in 16-18 week fetuses. The type of CVM is a major, but not the only, factor determining parental decision regarding pre and post-natal management. In a significant proportion of cases, CVM in fetuses is associated with extracardiac defects. The data of the Baltimore-Washington Infant Study shows that approximately 25% of all newborns with CVM (and almost a third of newborns with the most severe CVM, which are theoretically more readily detectable by fetal ultrasound) have non-cardiac malformations. The frequency and structure of associated defects in cases with different forms of CVM are reported. In some cases the extracardiac defects may be the primary determinant of outcome. In other cases defects of other systems may be manifestations of serious chromosomal abnormalities. Therefore, detailed ultrasound and cytogenetic study of each fetus with CVM detected by ultrasound is a necessary part of fetal evaluation. If the parents opt for continuation of the pregnancy, a geneticist should be involved in clinical evaluation of the infant after birth, especially if extracardiac abnormalities are evident or suspected. If DiGeorge sequence or Williams syndrome is suspected in an infant, specific molecular tests will be necessary to confirm (or to exclude) the diagnosis.

Original languageEnglish (US)
Pages (from-to)73-78
Number of pages6
JournalProgress in Pediatric Cardiology
Volume5
Issue number2
DOIs
StatePublished - Apr 1996
Externally publishedYes

Fingerprint

Cardiology
DiGeorge Syndrome
Heart Diseases
Fetus
Newborn Infant
Williams Syndrome
Baltimore
Cytogenetics
Chromosome Aberrations
Parents
Parturition
Technology
Pregnancy

Keywords

  • Cardiovascular malformations (CVM)
  • Fetal evaluation
  • Ultrasound technology

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Heart disease in infancy : A window to the world of fetal cardiology. / Lurie, Iosif W.; Ferencz, Charlotte; Brenner, Joel.

In: Progress in Pediatric Cardiology, Vol. 5, No. 2, 04.1996, p. 73-78.

Research output: Contribution to journalArticle

Lurie, Iosif W. ; Ferencz, Charlotte ; Brenner, Joel. / Heart disease in infancy : A window to the world of fetal cardiology. In: Progress in Pediatric Cardiology. 1996 ; Vol. 5, No. 2. pp. 73-78.
@article{3ffc850d88bb4f018bc1151288dda62a,
title = "Heart disease in infancy: A window to the world of fetal cardiology",
abstract = "Advances in ultrasound technology and its widespread application have enabled the discovery of the most serious cardiovascular malformations in 16-18 week fetuses. The type of CVM is a major, but not the only, factor determining parental decision regarding pre and post-natal management. In a significant proportion of cases, CVM in fetuses is associated with extracardiac defects. The data of the Baltimore-Washington Infant Study shows that approximately 25{\%} of all newborns with CVM (and almost a third of newborns with the most severe CVM, which are theoretically more readily detectable by fetal ultrasound) have non-cardiac malformations. The frequency and structure of associated defects in cases with different forms of CVM are reported. In some cases the extracardiac defects may be the primary determinant of outcome. In other cases defects of other systems may be manifestations of serious chromosomal abnormalities. Therefore, detailed ultrasound and cytogenetic study of each fetus with CVM detected by ultrasound is a necessary part of fetal evaluation. If the parents opt for continuation of the pregnancy, a geneticist should be involved in clinical evaluation of the infant after birth, especially if extracardiac abnormalities are evident or suspected. If DiGeorge sequence or Williams syndrome is suspected in an infant, specific molecular tests will be necessary to confirm (or to exclude) the diagnosis.",
keywords = "Cardiovascular malformations (CVM), Fetal evaluation, Ultrasound technology",
author = "Lurie, {Iosif W.} and Charlotte Ferencz and Joel Brenner",
year = "1996",
month = "4",
doi = "10.1016/1058-9813(95)00152-2",
language = "English (US)",
volume = "5",
pages = "73--78",
journal = "Progress in Pediatric Cardiology",
issn = "1058-9813",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Heart disease in infancy

T2 - A window to the world of fetal cardiology

AU - Lurie, Iosif W.

AU - Ferencz, Charlotte

AU - Brenner, Joel

PY - 1996/4

Y1 - 1996/4

N2 - Advances in ultrasound technology and its widespread application have enabled the discovery of the most serious cardiovascular malformations in 16-18 week fetuses. The type of CVM is a major, but not the only, factor determining parental decision regarding pre and post-natal management. In a significant proportion of cases, CVM in fetuses is associated with extracardiac defects. The data of the Baltimore-Washington Infant Study shows that approximately 25% of all newborns with CVM (and almost a third of newborns with the most severe CVM, which are theoretically more readily detectable by fetal ultrasound) have non-cardiac malformations. The frequency and structure of associated defects in cases with different forms of CVM are reported. In some cases the extracardiac defects may be the primary determinant of outcome. In other cases defects of other systems may be manifestations of serious chromosomal abnormalities. Therefore, detailed ultrasound and cytogenetic study of each fetus with CVM detected by ultrasound is a necessary part of fetal evaluation. If the parents opt for continuation of the pregnancy, a geneticist should be involved in clinical evaluation of the infant after birth, especially if extracardiac abnormalities are evident or suspected. If DiGeorge sequence or Williams syndrome is suspected in an infant, specific molecular tests will be necessary to confirm (or to exclude) the diagnosis.

AB - Advances in ultrasound technology and its widespread application have enabled the discovery of the most serious cardiovascular malformations in 16-18 week fetuses. The type of CVM is a major, but not the only, factor determining parental decision regarding pre and post-natal management. In a significant proportion of cases, CVM in fetuses is associated with extracardiac defects. The data of the Baltimore-Washington Infant Study shows that approximately 25% of all newborns with CVM (and almost a third of newborns with the most severe CVM, which are theoretically more readily detectable by fetal ultrasound) have non-cardiac malformations. The frequency and structure of associated defects in cases with different forms of CVM are reported. In some cases the extracardiac defects may be the primary determinant of outcome. In other cases defects of other systems may be manifestations of serious chromosomal abnormalities. Therefore, detailed ultrasound and cytogenetic study of each fetus with CVM detected by ultrasound is a necessary part of fetal evaluation. If the parents opt for continuation of the pregnancy, a geneticist should be involved in clinical evaluation of the infant after birth, especially if extracardiac abnormalities are evident or suspected. If DiGeorge sequence or Williams syndrome is suspected in an infant, specific molecular tests will be necessary to confirm (or to exclude) the diagnosis.

KW - Cardiovascular malformations (CVM)

KW - Fetal evaluation

KW - Ultrasound technology

UR - http://www.scopus.com/inward/record.url?scp=0029965817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029965817&partnerID=8YFLogxK

U2 - 10.1016/1058-9813(95)00152-2

DO - 10.1016/1058-9813(95)00152-2

M3 - Article

AN - SCOPUS:0029965817

VL - 5

SP - 73

EP - 78

JO - Progress in Pediatric Cardiology

JF - Progress in Pediatric Cardiology

SN - 1058-9813

IS - 2

ER -